CH633009A5 - Process for the preparation of new phenylpiperazine derivatives - Google Patents

Process for the preparation of new phenylpiperazine derivatives Download PDF

Info

Publication number
CH633009A5
CH633009A5 CH525781A CH696480A CH633009A5 CH 633009 A5 CH633009 A5 CH 633009A5 CH 525781 A CH525781 A CH 525781A CH 696480 A CH696480 A CH 696480A CH 633009 A5 CH633009 A5 CH 633009A5
Authority
CH
Switzerland
Prior art keywords
phenyl
optionally substituted
piperazine
formula
alkyl
Prior art date
Application number
CH525781A
Other languages
English (en)
French (fr)
Inventor
John Pomfret Verge
William Boffey Jamieson
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of CH633009A5 publication Critical patent/CH633009A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH525781A 1976-04-23 1977-04-13 Process for the preparation of new phenylpiperazine derivatives CH633009A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
CH633009A5 true CH633009A5 (en) 1982-11-15

Family

ID=10078930

Family Applications (2)

Application Number Title Priority Date Filing Date
CH455777A CH625802A5 (en) 1976-04-23 1977-04-13 Process for the preparation of phenylpiperazine derivatives
CH525781A CH633009A5 (en) 1976-04-23 1977-04-13 Process for the preparation of new phenylpiperazine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH455777A CH625802A5 (en) 1976-04-23 1977-04-13 Process for the preparation of phenylpiperazine derivatives

Country Status (34)

Country Link
JP (1) JPS52151183A (ru)
AR (2) AR222003A1 (ru)
AT (1) AT355579B (ru)
AU (1) AU514822B2 (ru)
BE (1) BE853899A (ru)
BG (2) BG27746A3 (ru)
CA (1) CA1087617A (ru)
CH (2) CH625802A5 (ru)
CS (1) CS196360B2 (ru)
DD (1) DD129790A5 (ru)
DE (1) DE2717415A1 (ru)
DK (1) DK176177A (ru)
ES (2) ES457988A1 (ru)
FI (1) FI63937C (ru)
FR (1) FR2348925A1 (ru)
GB (1) GB1575904A (ru)
GR (1) GR64084B (ru)
HU (1) HU176820B (ru)
IE (1) IE44730B1 (ru)
IL (1) IL51787A (ru)
LU (1) LU77170A1 (ru)
MX (1) MX4596E (ru)
NL (1) NL7704456A (ru)
NO (1) NO146710C (ru)
NZ (1) NZ183715A (ru)
OA (1) OA05643A (ru)
PH (1) PH14124A (ru)
PL (1) PL117466B1 (ru)
PT (1) PT66452B (ru)
RO (1) RO72831A (ru)
SE (1) SE7704536L (ru)
SU (2) SU664564A3 (ru)
YU (1) YU104477A (ru)
ZA (1) ZA771849B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
US5834499A (en) * 1994-03-11 1998-11-10 Yamanouchi Pharmaceutical Co., Ltd. 5-HT3 receptor agonist, novel thiazole derivative and intermediate thereof
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
CA2644069A1 (en) 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors

Also Published As

Publication number Publication date
LU77170A1 (ru) 1979-01-18
IL51787A0 (en) 1977-05-31
CH625802A5 (en) 1981-10-15
BG27746A3 (en) 1979-12-12
JPS52151183A (en) 1977-12-15
FR2348925B1 (ru) 1980-04-11
ATA285177A (de) 1979-08-15
SU727146A3 (ru) 1980-04-05
PL117466B1 (en) 1981-08-31
DE2717415A1 (de) 1977-11-10
NZ183715A (en) 1980-04-28
SE7704536L (sv) 1977-10-24
OA05643A (fr) 1981-04-30
RO72831B (ro) 1983-07-30
AR222635A1 (es) 1981-06-15
AR222003A1 (es) 1981-04-15
FI63937B (fi) 1983-05-31
GR64084B (en) 1980-01-21
BG28055A3 (en) 1980-02-25
DK176177A (da) 1977-10-24
RO72831A (ro) 1983-08-03
NO146710B (no) 1982-08-16
FR2348925A1 (fr) 1977-11-18
MX4596E (es) 1982-06-25
PT66452B (en) 1979-03-09
AU514822B2 (en) 1981-02-26
YU104477A (en) 1983-01-21
ES467948A1 (es) 1978-11-01
NO146710C (no) 1982-11-24
AU2438677A (en) 1978-10-26
HU176820B (en) 1981-05-28
NO771398L (no) 1977-10-25
DD129790A5 (de) 1978-02-08
PH14124A (en) 1981-02-26
NL7704456A (nl) 1977-10-25
AT355579B (de) 1980-03-10
FI771287A (ru) 1977-10-24
SU664564A3 (ru) 1979-05-25
PT66452A (en) 1977-05-01
FI63937C (fi) 1983-09-12
ES457988A1 (es) 1978-07-16
IE44730L (en) 1977-10-23
IL51787A (en) 1980-02-29
CA1087617A (en) 1980-10-14
PL197550A1 (pl) 1979-05-21
CS196360B2 (en) 1980-03-31
BE853899A (fr) 1977-10-24
GB1575904A (en) 1980-10-01
ZA771849B (en) 1978-11-29
IE44730B1 (en) 1982-03-10

Similar Documents

Publication Publication Date Title
KR930008450B1 (ko) 벤즈옥사졸유도체 및 이의 제조방법
US4438141A (en) Thiazolidine derivatives
AU661034B2 (en) Leukotriene biosynthesis inhibitors
EP2014652B1 (en) Activating agent for peroxisome proliferator activated receptor
FR2680512A1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5599826A (en) Thiazolidinediones and drugs containing them
JPH01143856A (ja) 抗アレルギーおよび抗炎症剤用2−アリール置換複素環式化合物
FR2692893A1 (fr) Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CA2294809A1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2766822A1 (fr) Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CH633009A5 (en) Process for the preparation of new phenylpiperazine derivatives
PL150631B1 (en) Method for manufacturing new heterocyclic products
EP1446393B1 (fr) Derives de 2-amino-thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible
US4139538A (en) Oxazolidinones as therapeutic agents
EP1446402A1 (fr) Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible
US4179442A (en) 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one
EP0579169B1 (en) Alkylenediamine derivatives
JPH08301841A (ja) スクアレン・エポキシダーゼ活性阻害剤
KR810000891B1 (ko) 페닐 피페라진 유도체의 제조방법
JPH10503172A (ja) 新しい1,1−ビス(ヘテロアゾリル)アルカン誘導体および神経保護剤としてのその使用
EP1299103B1 (fr) Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase
WO2003099812A1 (fr) Derives de phenyl-furane ou de phenyl-thiophene, leur preparation et leur application a titre de medicament
EP0565579B1 (fr) Derives d'imino-2 polyfluoroalkyl-6 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant
US3969351A (en) Morpholine containing isothiocyanobenzoxazoles
EP0424214A1 (fr) Dérivés de 5-[2-[[2-amino-2-oxoéthyl]méthylamino]éthyl]-2,3-dihydro-3-hydroxy-2-(4-méthoxy-phényl)-1,5(5H)-benzothiazépine-4-one, leur préparation et leur application en thérapeutique

Legal Events

Date Code Title Description
PL Patent ceased